Evidence map›Paper›PMID 26617626›Full record

ArticleFrontiers in plant science2015

Plant Innate Immunity Multicomponent Model.

Giuseppe Andolfo, Maria R Ercolano

Abstract read
In one paragraph

Article in Frontiers in plant science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed.

  1. Beyond Resistance Genes: Silencing Susceptibility.International journal of molecular sciences · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Parallel, Continuous Monitoring and Quantification of Programmed Cell Death in Plant Tissue.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  6. Review
  7. The First Genome-Wide Mildew Locus O Genes Characterization in theInternational journal of molecular sciences · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Prediction of NB-LRR resistance genes based on full-length sequence homology.The Plant journal : for cell and molecular biology · 2022
    Article
  17. Article
  18. Review
  19. A novel elicitor protein phosphopentomutase fromFrontiers in plant science · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Giuseppe AndolfoDepartment of Agricultural Sciences, University of Naples 'Federico II' Portici, Italy.
Maria R ErcolanoDepartment of Agricultural Sciences, University of Naples 'Federico II' Portici, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our understanding of plant-pathogen interactions is making rapid advances in order to address issues of global importance such as improving agricultural productivity and sustainable food security. Innate immunity has evolved in plants, resulting in a wide diversity of defense mechanisms adapted to specific threats. The postulated PTI/ETI model describes two perception layers of plant innate immune system, which belong to a first immunity component of defense response activation. To better describe the sophisticated defense system of plants, we propose a new model of plant immunity. This model considers the plant's ability to distinguish the feeding behavior of their many foes, such as a second component that modulates innate immunity. This hypothesis provides a new viewpoint highlighting the relevance of hormone crosstalk and primary metabolism in regulating plant defense against the different behaviors of pathogens with the intention to stimulate further interest in this research area.

Indexed as

biotrophicIACIMCnecrotrophicphytohormoneplant defenseprimary metabolism

Identifiers

PMID26617626
PMCPMC4643146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.